Summary:
Click image to enlarge
This research study is being conducted to see if the study vaccine (NVX-CoV2705) prevents COVID-19 and to provide additional information on the safety of the study vaccine in adults 50 to 64 years old who do not have an underlying condition that puts them at high risk for severe outcomes from COVID-19
Qualified Participants Must:
• Be between 50 - 64 years
•
Cannot have the following health conditions: asthma, diabetes, heart disease, obesity, depression, bipolar disorder, kidney disease or any other serious medical condition
•
Cannot be a smoker
Qualified Participants May Receive:
To cover costs associated with study participation, Acevedo Clinical Research Associates will reimburse you $175 per visit following each completed on-site visit, $50 per visit following each completed telephone/telehealth visit, and $60 at Day 42, Day 90, and Day 180 if the diary card is returned with ≥ 80% compliance level.